India's First Dengue Vaccine Enters Phase-3 Clinical Trials- All You Should Know

Dengue Vaccine in India

Text

Updated Aug 14, 2024 | 07:06 PM IST

SummaryIndia’s first dengue vaccine, DengiAll, is in phase-3 clinical trials. Developed by Panacea Biotec and ICMR, the vaccine aims to offer comprehensive protection against dengue, potentially transforming public health outcomes and reducing the disease’s impact.

End of Article

King Charles Opens Up About His Cancer Treatment, Calls Himself 'One Of The Statistics'

King Charles Opens Up About His Cancer Treatment, Calls Himself 'One Of The Statistics'

Credit: Canva

Text

Updated May 1, 2025 | 09:16 AM IST

SummaryKing Charles described himself as one of the "statistics" among the 390,000 who "sadly" receive a cancer diagnosis in the UK each year.

End of Article

Hajj Pilgrims Must Get Meningitis Vaccines: UKHSA

Hajj Pilgrims Must Get meningitis vaccines: UKHSA

Credits: Canva

Text

Updated Apr 30, 2025 | 03:00 PM IST

SummaryUKHSA urges Hajj and Umrah pilgrims to get MenACWY vaccine amid MenW outbreak; 5 UK cases linked to recent Saudi travel.

End of Article

FDA Greenlights Zevaskyn for Rare Genetic Skin Condition

FDA Greenlights Zevaskyn for Rare Genetic Skin Condition

Credits: Canva

Text

Updated Apr 30, 2025 | 08:00 AM IST

SummaryWith FDA approval, Zevaskyn is set to be a game-changer in the treatment of recessive dystrophic epidermolysis bullosa—offering patients more than just relief, but a meaningful step toward healing.

End of Article